Oct
12
Filed Under Articles, Bisphenol-A
I saw this study around but our friends at The Soft Landing blogged it yesterday so I wanted to point it out. In yet another study, this one from the University of Cincinnati says that like estrogen, Bisphenol-a may actually protect cancer cells, making cancer treatments less effective.
The new University of Cincinnati study says that Bisphenol-A may reduce the effectiveness of chemotherapy treatments. Bisphenol-A seems to bolster proteins that protect cancer cells, according to the research, published in the peer-reviewed journal Environmental Health Perspectives.
Scary and yet another straw on the camels back. Evidence is accumulating and soon the FDA will have no choice but to consider it in their evaluation.
Found at The Soft Landing, article from The Daily Green.
Here is a bit from the University of Cincinnati:
“BPA does not increase cancer cell proliferation like DES does,” she says. “It’s actually acting by protecting existing cancer cells from dying in response to anti-cancer drugs, making chemotherapy significantly less effective.”
…
These data,” study authors write, “provide considerable support to the accumulating evidence that BPA is hazardous to human health.”
Read the article regarding the study from University of Cincinnati for more details.
Related articles:
- New Bisphenol-A Study in the News
- Bisphenol-A: How Much Evidence Do We Need?
- New Research Links Bisphenol-a to Metabolic Syndrome
